Biomarkers in diagnosing and therapeutic monitoring of tuberculosis: a review
- PMID: 39097795
- PMCID: PMC11299445
- DOI: 10.1080/07853890.2024.2386030
Biomarkers in diagnosing and therapeutic monitoring of tuberculosis: a review
Abstract
Tuberculosis (TB) continues to pose a significant health challenge worldwide, emphasizing the importance of prompt diagnosis and efficient monitoring of treatment outcomes for effective disease control. Biomarkers have become increasingly important in the realm of TB diagnoses and treatment. The objective of this comprehensive review is to examine the present state of biomarkers employed in the diagnosis of TB, monitoring the response to treatment, and predicting treatment outcomes. In this study, we undertake a comprehensive examination of the diverse biomarkers utilized in TB diagnoses, spanning molecular, immunological, and other novel methodologies. Furthermore, we examine the potential of biomarkers in the context of therapeutic monitoring, assessment of treatment effectiveness, and anticipation of drug resistance. Additionally, this paper presents future prospects regarding the utilization of biomarkers in the therapy of tuberculosis.
Keywords: Biomarkers; diagnosis; treatment monitoring; tuberculosis.
Conflict of interest statement
No potential conflict of interest was reported by the author(s).
References
-
- WHO . Global Tuberculosis Report. World Health Organization. 2021.
-
- Strategy WET. Draft global strategy and targets for tuberculosis prevention, care and control after 2015. Documentation for World Health Assembly; 2013.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical